000 | 01653 a2200505 4500 | ||
---|---|---|---|
005 | 20250516092241.0 | ||
264 | 0 | _c20121109 | |
008 | 201211s 0 0 eng d | ||
022 | _a1095-6859 | ||
024 | 7 |
_a10.1016/j.ygyno.2012.05.001 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aHyman, David M | |
245 | 0 | 0 |
_aOutcomes of primary surgical cytoreduction in patients with BRCA-associated high-grade serous ovarian carcinoma. _h[electronic resource] |
260 |
_bGynecologic oncology _cAug 2012 |
||
300 |
_a224-8 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aAged |
650 | 0 | 4 | _aCohort Studies |
650 | 0 | 4 |
_aCystadenocarcinoma, Serous _xgenetics |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aGenes, BRCA1 |
650 | 0 | 4 | _aGenes, BRCA2 |
650 | 0 | 4 | _aGerm-Line Mutation |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 | _aNeoplasm Grading |
650 | 0 | 4 | _aNeoplasm Staging |
650 | 0 | 4 |
_aOvarian Neoplasms _xgenetics |
650 | 0 | 4 | _aRetrospective Studies |
650 | 0 | 4 | _aSurvival Analysis |
650 | 0 | 4 | _aTreatment Outcome |
700 | 1 | _aLong, Kara C | |
700 | 1 | _aTanner, Edward J | |
700 | 1 | _aGrisham, Rachel N | |
700 | 1 | _aArnold, Angela G | |
700 | 1 | _aBhatia, Jasmine | |
700 | 1 | _aPhillips, Mary F | |
700 | 1 | _aSpriggs, David R | |
700 | 1 | _aSoslow, Robert A | |
700 | 1 | _aKauff, Noah D | |
700 | 1 | _aLevine, Douglas A | |
773 | 0 |
_tGynecologic oncology _gvol. 126 _gno. 2 _gp. 224-8 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.ygyno.2012.05.001 _zAvailable from publisher's website |
999 |
_c21775536 _d21775536 |